Betty B Yao Selected Research

A-836339

1/2011	Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats.
1/2009	Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Betty B Yao Research Topics

Disease

4	Infections 10/2020 - 11/2018
3	Neuralgia (Stump Neuralgia) 01/2011 - 01/2009
3	Hyperalgesia 01/2011 - 03/2008
2	Fibrosis (Cirrhosis) 10/2020 - 01/2019
2	Body Weight (Weight, Body) 01/2020 - 08/2006
2	Chronic Hepatitis C 01/2020 - 01/2019
2	Pain (Aches) 01/2011 - 01/2009
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2006 - 04/2005
2	Cognitive Dysfunction 04/2005 - 06/2003
1	Hepatitis C 01/2020
1	Liver Diseases (Liver Disease) 01/2019
1	Hyperthermia 08/2006
1	Schizophrenia (Dementia Praecox) 04/2005
1	Alzheimer Disease (Alzheimer's Disease) 04/2005
1	Nervous System Diseases (Neurological Disorders) 06/2003

Drug/Important Bio-Agent (IBA)

3	CannabinoidsIBA 01/2011 - 01/2009
3	Histamine H3 Receptors (Histamine H3 Receptor)IBA 04/2005 - 06/2003
2	glecaprevir and pibrentasvirIBA 10/2020 - 01/2019
2	Ritonavir (Norvir)FDA Link 01/2020 - 11/2018
2	paritaprevirIBA 01/2020 - 11/2018
2	ombitasvirIBA 01/2020 - 11/2018
2	dasabuvirIBA 01/2020 - 11/2018
2	A-836339IBA 01/2011 - 01/2009
2	Freund's AdjuvantIBA 01/2009 - 03/2008
2	Neurotransmitter Agents (Neurotransmitter)IBA 04/2005 - 06/2003
1	P-300IBA 10/2020
1	SolutionsIBA 01/2020
1	TabletsIBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	pibrentasvirIBA 01/2019
1	glecaprevirIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	AM 1241IBA 01/2011
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2011
1	salicylhydroxamic acid (SHAM)IBA 01/2011
1	GTP-Binding Proteins (G-Protein)IBA 01/2009
1	AmidesIBA 01/2009
1	cyclopropanecarboxylic acidIBA 01/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2009
1	CB2 Cannabinoid ReceptorIBA 01/2009
1	Capsaicin (Zostrix)FDA Link 01/2009
1	Methylphenidate (Ritalin)FDA LinkGeneric 08/2006
1	LigandsIBA 08/2006
1	Histamine (Histamine Dihydrochloride)FDA Link 08/2006
1	4- ((3- (4- (2- aminopropanoyl)- 1- piperazinyl)propoxy)phenyl)cyclopropylmethanoneIBA 08/2006
1	ciproxifanIBA 08/2006
1	imidazoleIBA 08/2006
1	Histamine H3 AntagonistsIBA 04/2005
1	benzofuranIBA 04/2005
1	benzonitrileIBA 04/2005
1	4- (2- (2- ((2r)- 2- methyl- 1- pyrrolidinyl)ethyl)- 5- benzofuranyl)- benzonitrile (ABT 239)IBA 04/2005

Therapy/Procedure

1	Ligation 01/2011